Treatment with Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats

Table 3

Mean value of tissue malondialdehyde in treated and untreated groups of animals and 95% confidence interval (mean ± SD, CI) (Comparisons: treated animals versus group 1).

Group	Tissue malondialdehyde (μM/L)	value
1	2.74 ± 0.36, (2.51–2.96)
2	2.03 ± 0.29, (1.85–2.209)
3	1.12 ± 0.22, (0.944–1.296)	0.017
4	1.62 ± 0.31, (1.37–1.868)	0.011
5	1.68 ± 0.19, (1.52–1.832)	0.030
6	1.71 ± 0.36, (1.42–1.99)	0.044
7	2.11 ± 0.43, (1.76–2.46)	0.272
8	1.98 ± 0.27, (1.76–2.19)	0.316
9	1.72 ± 0.16, (1.59–1.84)	0.023